v3.26.3
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
 12 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Operating activities:    
Net loss $ (1,404,000) $ (113,000)
Adjustments to reconcile net loss to net cash used in operating activities:    
Debt discount amortization 15,000 0
Change in fair value of derivative liability (24,000) 0
Fair value of warrants granted for services 0 195,000
Fair value of common stock issued for services 394,000 6,000
Gain on patent assignment 0 (880,000)
Effect of changes in:    
Accounts receivable 10,000 (10,000)
Prepaid expenses 10,000 (11,000)
Operating lease right-of-use assets 0 42,000
Accounts payable and accrued expenses 99,000 0
Accrued payroll – related parties 129,000 11,000
Accrued interest 16,000 0
Operating lease liabilities 0 (46,000)
Net cash used in operating activities (755,000) (806,000)
Investing activities:    
Proceeds from patent assignment 0 880,000
Net cash provided by investing activities 0 880,000
Financing activities:    
Proceeds from convertible notes payable 60,000 0
Proceeds from common stock units 248,000 0
Proceeds from promissory notes payable – related party 115,000 0
Proceeds from bridge note payable 100,000 0
Repayment of notes payable 0 (4,000)
Cash provided by (used in) financing activities 523,000 (4,000)
Net (decrease) increase in cash and cash equivalents (232,000) 70,000
Cash and cash equivalents, beginning of period 249,000 179,000
Cash and cash equivalents, end of period 17,000 249,000
Supplemental disclosures of cash flow information:    
Cash paid for interest 9,000 6,000
Cash paid for income taxes 0 0
Non-Cash Investing and Financing Activities    
Conversion feature of convertible notes payable accounted as derivative liability 38,000 0
Fair value of common stock and warrants issued to settle accrued payroll and payroll taxes – related parties 0 190,000
Extinguishment of accrued payroll and payroll taxes – related parties treated as contribution of capital $ 0 $ 271,000